Tetralogic Pharma (TLOG) Stock Statistics & Valuation Metrics
Total Valuation
Tetralogic Pharma has a market cap or net worth of $24.00. The enterprise value is ―.
- Market Cap
- $24.00
- Enterprise Value
- ―
Share Statistics
Tetralogic Pharma has 24,465,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 24,465,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.02%
Financial Efficiency
Tetralogic Pharma’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.
- Return on Equity (ROE)
- 0.00
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- 0.00%
- Return on Capital Employed (ROCE)
- 0.00
- Revenue Per Employee
- 0
- Profits Per Employee
- 0
- Employee Count
- 29
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Tetralogic Pharma is 0.00. Tetralogic Pharma’s PEG ratio is ―.
- PE Ratio
- 0.00
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- ―
Income Statement
In the last 12 months, Tetralogic Pharma had revenue of 0 and earned 0 in profits. Earnings per share was 0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- 0
- Pretax Income
- 0
- Net Income
- 0
- EBITDA
- 0
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was -23.88M and capital expenditures -666, giving a free cash flow of -23.88M billion.
- Operating Cash Flow
- -23.88M
- Free Cash Flow
- -23.88M
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Tetralogic Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- ―
Stock Price Statistics
- Beta
- 166.26
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Tetralogic Pharma as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.00
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Tetralogic Pharma has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Tetralogic Pharma EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.00
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Tetralogic Pharma has $5.89M in cash and marketable securities with $30.81M in debt, giving a net cash position of -$24.92M billion.
- Cash & Marketable Securities
- $5.89M
- Total Debt
- $30.81M
- Net Cash
- -$24.92M
- Net Cash Per Share
- -$1.02
- Tangible Book Value Per Share
- ―
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%